—CMG
— • —
$34.09
P/E
29.82
PEG
0.11
FCF Yield
—
Rev Growth YoY
+541.0% YoY
Gross Margin
3062.0%
Health Score
5/10
D/E Ratio
—
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, making a precise business description impossible. Based on available financial characteristics — including extraordinary gross margins, a debt-free balance sheet, and explosive revenue growth — this appears to be a very early-stage or niche-revenue company operating in a high-margin vertical. With market capitalisation data unavailable, the cap tier cannot be confirmed, though the valuation ratios and price point suggest a smaller company.
Financial Health
**Score: 5/10** The balance sheet carries zero debt (Debt/Equity of 0.0x), which is a clear strength and eliminates near-term solvency risk. However, the current ratio of 1.23x indicates only modest short-term liquidity headroom — the company can cover its current liabilities, but with limited buffer...
Risk Assessment
- **DATA INTEGRITY:** Gross margin of 3,062% and net margin of 1,288% are not economically coherent for any standard business and strongly suggest data normalisation errors, one-time items, or a very unusual revenue recognition structure. - **TECHNICALS:** The stock is trading below both its 50-day and 200-day moving averages, and a death cross formation (50-day crossing below 200-day) is confirmed — a bearish technical pattern. - **FCF VISIBILITY:** Free cash flow is unavailable, meaning the high reported margins cannot be verified as real cash earnings; capital allocation and sustainability are unassessable. - **MISSING CONTEXT:** TTM Revenue and TTM Net Income are both absent, preventing any absolute-scale assessment of the business size or earnings power. - **GROWTH CONCENTRATION RISK:** Revenue growth of 541% YoY with no QoQ data creates significant uncertainty about whether this growth is structural or a one-period anomaly. ---...